Phospholipase C beta 1 deficiency is associated with early-onset epileptic encephalopathy

M. A. Kurian, E. Meyer, G. Vassallo, N. V. Morgan, N. Prakash, S. Pasha, N. A. Hai, S. Shuib, F. Rahman, E. Wassmer, J. H. Cross, F. J. O'Callaghan, J. P. Osborne, I. E. Scheffer, P. Gissen, E. R. Maher

Research output: Contribution to journalArticle

69 Citations (Scopus)

Abstract

The epileptic encephalopathies of infancy and childhood are a collection of epilepsy disorders characterized by refractory, severe seizures and poor neurological outcome, in which the mechanism of disease is poorly understood. We report the clinical presentation and evolution of epileptic encephalopathy in a patient, associated with a loss-of-function mutation in the phospholipase C-beta 1 gene. We ascertained a consanguineous family containing a male infant who presented with early-onset epileptic encephalopathy for detailed clinical phenotyping and molecular genetic investigation. In addition, a cohort of 12 consanguineous families of children with infantile spasms were analysed for linkage to the phospholipase C-beta 1 gene locus. The male infant presented with tonic seizures in early infancy and subsequently developed infantile spasms. Over time, he developed drug-resistant epilepsy associated with severe neurological regression and failure to thrive. Molecular genetic investigation revealed a homozygous loss-of-function 0.5-Mb deletion, encompassing the promoter element and exons 1, 2 and 3 of phospholipase C-beta 1 in the index case. Linkage to the phospholipase C-beta 1 locus was excluded in the 12 other consanguineous families, consistent with genetic heterogeneity in this disorder. Although phospholipase C-beta 1 deficiency has not previously been reported in humans, the Plcb1 homozygote knockout mouse displays early-onset severe tonic seizures and growth retardation, thus recapitulating the human phenotype. Phospholipase C-beta 1 has important functions in both hippocampal muscarinic acetylcholine receptor signalling and in cortical development. Thus, the discovery of a phospholipase C-beta 1 mutation allows us to propose a novel potential underlying mechanism in early-onset epileptic encephalopathy.
Original languageEnglish
Pages (from-to)2964-2970
Number of pages7
JournalBrain
Volume133
Issue number10
DOIs
Publication statusPublished - Oct 2010

Fingerprint

Phospholipase C beta
Brain Diseases
Infantile Spasms
Seizures
Molecular Biology
Failure to Thrive
Mutation
Genetic Heterogeneity
Homozygote
Muscarinic Receptors
Knockout Mice
Genes
Exons
Epilepsy
Phenotype

Keywords

  • epileptic encephalopathy
  • muscarinic acetylcholine receptor
  • infantile spasms
  • hippocampus
  • phospholipase C-beta 1
  • PLCB1

Cite this

Kurian, M. A., Meyer, E., Vassallo, G., Morgan, N. V., Prakash, N., Pasha, S., ... Maher, E. R. (2010). Phospholipase C beta 1 deficiency is associated with early-onset epileptic encephalopathy. Brain, 133(10), 2964-2970. https://doi.org/10.1093/brain/awq238

Phospholipase C beta 1 deficiency is associated with early-onset epileptic encephalopathy. / Kurian, M. A.; Meyer, E.; Vassallo, G.; Morgan, N. V.; Prakash, N.; Pasha, S.; Hai, N. A.; Shuib, S.; Rahman, F.; Wassmer, E.; Cross, J. H.; O'Callaghan, F. J.; Osborne, J. P.; Scheffer, I. E.; Gissen, P.; Maher, E. R.

In: Brain, Vol. 133, No. 10, 10.2010, p. 2964-2970.

Research output: Contribution to journalArticle

Kurian, MA, Meyer, E, Vassallo, G, Morgan, NV, Prakash, N, Pasha, S, Hai, NA, Shuib, S, Rahman, F, Wassmer, E, Cross, JH, O'Callaghan, FJ, Osborne, JP, Scheffer, IE, Gissen, P & Maher, ER 2010, 'Phospholipase C beta 1 deficiency is associated with early-onset epileptic encephalopathy', Brain, vol. 133, no. 10, pp. 2964-2970. https://doi.org/10.1093/brain/awq238
Kurian MA, Meyer E, Vassallo G, Morgan NV, Prakash N, Pasha S et al. Phospholipase C beta 1 deficiency is associated with early-onset epileptic encephalopathy. Brain. 2010 Oct;133(10):2964-2970. https://doi.org/10.1093/brain/awq238
Kurian, M. A. ; Meyer, E. ; Vassallo, G. ; Morgan, N. V. ; Prakash, N. ; Pasha, S. ; Hai, N. A. ; Shuib, S. ; Rahman, F. ; Wassmer, E. ; Cross, J. H. ; O'Callaghan, F. J. ; Osborne, J. P. ; Scheffer, I. E. ; Gissen, P. ; Maher, E. R. / Phospholipase C beta 1 deficiency is associated with early-onset epileptic encephalopathy. In: Brain. 2010 ; Vol. 133, No. 10. pp. 2964-2970.
@article{d43b89144ce54c92a739e0bb56c98bbc,
title = "Phospholipase C beta 1 deficiency is associated with early-onset epileptic encephalopathy",
abstract = "The epileptic encephalopathies of infancy and childhood are a collection of epilepsy disorders characterized by refractory, severe seizures and poor neurological outcome, in which the mechanism of disease is poorly understood. We report the clinical presentation and evolution of epileptic encephalopathy in a patient, associated with a loss-of-function mutation in the phospholipase C-beta 1 gene. We ascertained a consanguineous family containing a male infant who presented with early-onset epileptic encephalopathy for detailed clinical phenotyping and molecular genetic investigation. In addition, a cohort of 12 consanguineous families of children with infantile spasms were analysed for linkage to the phospholipase C-beta 1 gene locus. The male infant presented with tonic seizures in early infancy and subsequently developed infantile spasms. Over time, he developed drug-resistant epilepsy associated with severe neurological regression and failure to thrive. Molecular genetic investigation revealed a homozygous loss-of-function 0.5-Mb deletion, encompassing the promoter element and exons 1, 2 and 3 of phospholipase C-beta 1 in the index case. Linkage to the phospholipase C-beta 1 locus was excluded in the 12 other consanguineous families, consistent with genetic heterogeneity in this disorder. Although phospholipase C-beta 1 deficiency has not previously been reported in humans, the Plcb1 homozygote knockout mouse displays early-onset severe tonic seizures and growth retardation, thus recapitulating the human phenotype. Phospholipase C-beta 1 has important functions in both hippocampal muscarinic acetylcholine receptor signalling and in cortical development. Thus, the discovery of a phospholipase C-beta 1 mutation allows us to propose a novel potential underlying mechanism in early-onset epileptic encephalopathy.",
keywords = "epileptic encephalopathy, muscarinic acetylcholine receptor, infantile spasms, hippocampus, phospholipase C-beta 1, PLCB1",
author = "Kurian, {M. A.} and E. Meyer and G. Vassallo and Morgan, {N. V.} and N. Prakash and S. Pasha and Hai, {N. A.} and S. Shuib and F. Rahman and E. Wassmer and Cross, {J. H.} and O'Callaghan, {F. J.} and Osborne, {J. P.} and Scheffer, {I. E.} and P. Gissen and Maher, {E. R.}",
year = "2010",
month = "10",
doi = "10.1093/brain/awq238",
language = "English",
volume = "133",
pages = "2964--2970",
journal = "Brain",
issn = "0006-8950",
publisher = "Oxford University Press",
number = "10",

}

TY - JOUR

T1 - Phospholipase C beta 1 deficiency is associated with early-onset epileptic encephalopathy

AU - Kurian, M. A.

AU - Meyer, E.

AU - Vassallo, G.

AU - Morgan, N. V.

AU - Prakash, N.

AU - Pasha, S.

AU - Hai, N. A.

AU - Shuib, S.

AU - Rahman, F.

AU - Wassmer, E.

AU - Cross, J. H.

AU - O'Callaghan, F. J.

AU - Osborne, J. P.

AU - Scheffer, I. E.

AU - Gissen, P.

AU - Maher, E. R.

PY - 2010/10

Y1 - 2010/10

N2 - The epileptic encephalopathies of infancy and childhood are a collection of epilepsy disorders characterized by refractory, severe seizures and poor neurological outcome, in which the mechanism of disease is poorly understood. We report the clinical presentation and evolution of epileptic encephalopathy in a patient, associated with a loss-of-function mutation in the phospholipase C-beta 1 gene. We ascertained a consanguineous family containing a male infant who presented with early-onset epileptic encephalopathy for detailed clinical phenotyping and molecular genetic investigation. In addition, a cohort of 12 consanguineous families of children with infantile spasms were analysed for linkage to the phospholipase C-beta 1 gene locus. The male infant presented with tonic seizures in early infancy and subsequently developed infantile spasms. Over time, he developed drug-resistant epilepsy associated with severe neurological regression and failure to thrive. Molecular genetic investigation revealed a homozygous loss-of-function 0.5-Mb deletion, encompassing the promoter element and exons 1, 2 and 3 of phospholipase C-beta 1 in the index case. Linkage to the phospholipase C-beta 1 locus was excluded in the 12 other consanguineous families, consistent with genetic heterogeneity in this disorder. Although phospholipase C-beta 1 deficiency has not previously been reported in humans, the Plcb1 homozygote knockout mouse displays early-onset severe tonic seizures and growth retardation, thus recapitulating the human phenotype. Phospholipase C-beta 1 has important functions in both hippocampal muscarinic acetylcholine receptor signalling and in cortical development. Thus, the discovery of a phospholipase C-beta 1 mutation allows us to propose a novel potential underlying mechanism in early-onset epileptic encephalopathy.

AB - The epileptic encephalopathies of infancy and childhood are a collection of epilepsy disorders characterized by refractory, severe seizures and poor neurological outcome, in which the mechanism of disease is poorly understood. We report the clinical presentation and evolution of epileptic encephalopathy in a patient, associated with a loss-of-function mutation in the phospholipase C-beta 1 gene. We ascertained a consanguineous family containing a male infant who presented with early-onset epileptic encephalopathy for detailed clinical phenotyping and molecular genetic investigation. In addition, a cohort of 12 consanguineous families of children with infantile spasms were analysed for linkage to the phospholipase C-beta 1 gene locus. The male infant presented with tonic seizures in early infancy and subsequently developed infantile spasms. Over time, he developed drug-resistant epilepsy associated with severe neurological regression and failure to thrive. Molecular genetic investigation revealed a homozygous loss-of-function 0.5-Mb deletion, encompassing the promoter element and exons 1, 2 and 3 of phospholipase C-beta 1 in the index case. Linkage to the phospholipase C-beta 1 locus was excluded in the 12 other consanguineous families, consistent with genetic heterogeneity in this disorder. Although phospholipase C-beta 1 deficiency has not previously been reported in humans, the Plcb1 homozygote knockout mouse displays early-onset severe tonic seizures and growth retardation, thus recapitulating the human phenotype. Phospholipase C-beta 1 has important functions in both hippocampal muscarinic acetylcholine receptor signalling and in cortical development. Thus, the discovery of a phospholipase C-beta 1 mutation allows us to propose a novel potential underlying mechanism in early-onset epileptic encephalopathy.

KW - epileptic encephalopathy

KW - muscarinic acetylcholine receptor

KW - infantile spasms

KW - hippocampus

KW - phospholipase C-beta 1

KW - PLCB1

UR - http://www.scopus.com/inward/record.url?scp=77957686537&partnerID=8YFLogxK

UR - http://dx.doi.org/10.1093/brain/awq238

U2 - 10.1093/brain/awq238

DO - 10.1093/brain/awq238

M3 - Article

VL - 133

SP - 2964

EP - 2970

JO - Brain

JF - Brain

SN - 0006-8950

IS - 10

ER -